Affiliation:
1. Universidade Federal de Minas Gerais, BRAZIL
2. Universidade Federal do Rio Grande do Sul, Brazil
3. Presidente de Honra do Núcleo Brasileiro para Estudo do Helicobacter, Brazil
4. Universidade Federal do Piauí, Brasil
5. Universidade de São Paulo, Brasil
Abstract
Significant progress has been obtained since the Second Brazilian Consensus Conference on Helicobacter pylori Infection held in 2004, in São Paulo, SP, Brazil, and justify a third meeting to establish updated guidelines on the current management of H. pylori infection. The Third Brazilian Consensus Conference on H pylori Infection was organized by the Brazilian Nucleus for the Study of Helicobacter, a Department of the Brazilian Federation of Gastroenterology and took place on April 12-15, 2011, in Bento Gonçalves, RS, Brazil. Thirty-one delegates coming from the five Brazilian regions and one international guest, including gastroenterologists, pathologists, epidemiologists, and pediatricians undertook the meeting. The participants were allocated in one of the five main topics of the meeting: H pylori, functional dyspepsia and diagnosis; H pylori and gastric cancer; H pylori and other associated disorders; H pylori treatment and retreatment; and, epidemiology of H pylori infection in Brazil. The results of each subgroup were submitted to a final consensus voting to all participants. Relevant data were presented, and the quality of evidence, strength of recommendation, and level of consensus were graded. Seventy per cent and more votes were considered as acceptance for the final statement. This article presents the main recommendations and conclusions to guide Brazilian doctors involved in the management of H pylori infection.
Reference216 articles.
1. Prevalence and risk factors associated with Helicobacter pylori infection in native populations from Brazilian Western Amazon;Almeida-Cunha RP;Trans R Soc Trop Med Hyg,2003
2. Host-bacterial interactions in Helicobacter pylori infection;Amieva MR;Gastroenterology,2008
3. Platelet count response to H pylori treatment in patients with immune thrombocytopenic purpura with and without H pylori infection: a systematic review;Arnold DM;Haematologica,2009
4. Efficacy and safety of levofloxacin, clarithromycin and csomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study;Assem M;Eur J Int Med,2010
5. Projeto Diretrizes,2000
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献